Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/12893
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRada, Elsa-
dc.contributor.authorUlrich, Mariam-
dc.contributor.authorAranzazu, Nacarid-
dc.contributor.authorRodriguez, Vestalia-
dc.contributor.authorCenteno, Marta-
dc.contributor.authorGonzalez, Ivonne-
dc.contributor.authorSantaella, Carlos-
dc.contributor.authorRodriguez, Morella-
dc.contributor.authorConvit, Jacinto-
dc.date.accessioned2015-11-24T17:09:31Z-
dc.date.available2015-11-24T17:09:31Z-
dc.date.issued1996-03-17-
dc.identifier.urihttp://hdl.handle.net/10872/12893-
dc.description.abstractIn our present study, we report an annual follow up for at least 5 years of CMI and levels of serum antibody to PGL-I in MB patients treated with MDT alone as well as with MDT +IMT. The preliminary results of the determination of serum nitrite levels in both MB and PB patients are also reported.es_VE
dc.language.isoenes_VE
dc.publisherInternational Journal of Leprosy 65(3):320-327es_VE
dc.subjectmultidrug therapyes_VE
dc.subjectimmunotherapyes_VE
dc.subjectleprosyes_VE
dc.titleA follow-up study of multibacillary Hansen´disease patients treated with multidrug therapy (MDT) or MDT+immunotherapyes_VE
dc.typeArticlees_VE
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
Pub 1996.pdf129.42 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.